癫痫发作后成鼠及幼鼠海马神经发生的改变

目的:观察幼鼠及成鼠癫痫发作后海马神经发生的变化。方法:选用3周龄和成年雄性SD大鼠,氯化锂-匹罗卡品药物点燃造模,造模成功后根据溴脱氧尿嘧啶核苷(BrdU)注射时间点分为24 h组、2周组,并设相应的对照组。通过免疫荧光染色技术在激光共聚焦显微镜下观察幼鼠及成年鼠海马齿状回颗粒细胞层神经细胞的增殖情况。结果:(1)幼鼠24 h及2周实验组海马齿状回颗粒细胞层BrdU阳性细胞数均显著高于相应对照组(P<0.05),且24 h组较2周组显著增多(P<0.05);(2)成年鼠24 h实验组的BrdU阳性细胞数明显多于相应对照组(P<0.05),而2周组则相反(P<0.05)。结论:癫痫发作可导致海马神经发生的改变,幼鼠癫痫发作后海马齿状回颗粒细胞层神经细胞增殖显著升高,但随着时间延长呈下降趋势。慢性癫痫发作可引起成年鼠海马神经细胞增殖的降低。     

成年大鼠脑室下层细胞表达GFR-α_1的免疫组织化学研究

观察胶质细胞源性神经营养因子受体-α1 (GFR -α1 )在成年大鼠脑室下层(SVZ)细胞的表达,探讨胶质细胞源性神经营养因子(GDNF)对SVZ细胞的作用。成年大鼠SVZ组织冰冻切片,采用GFR -α1 结合5- 溴脱氧尿苷(BrdU)的免疫组织化学单标记与双标记方法,对成年大鼠SVZ进行观察。在成年大鼠SVZ可见GFR- α1 阳性细胞、BrdU阳性细胞和GFR- α1 /BrdU双标记细胞,且三种阳性细胞的分布趋势相似。结果提示GDNF可能参与调节成年哺乳动物脑内SVZ细胞的增殖、分化和迁移。     

Proliferation and differentiation of neural precursors in hippocampus and dentate gyrus after intracerebral hemorrhage in adult rats

目的:观察成年大鼠脑出血后海马齿状回神经前体细胞的增殖与分化,探讨脑出血后神经前体细胞的变化规律.方法:制作大鼠脑出血模型,5-溴脱氧尿嘧啶核苷(BrdU)腹腔注射标记增殖细胞,用免疫组织化学法检测大鼠海马齿状回BrdU、神经元核抗原(NeuN)、胶质纤维酸性蛋白(GFAP)阳性细胞数的变化.结果:正常组和假手术组大鼠海马齿状回均有少量BrdU阳性细胞,脑出血后大鼠各时间段的BrdU阳性细胞均较正常组和假手术组增加,7d组达到峰值后逐渐下降,28 d组仍高于正常组和假手术组.正常成年大鼠海马齿状回可见少量BrdU/NeuN和BrdU/GFAP双标阳性细胞,脑出血后双标阳性细胞数较正常组增加.结论:脑出血后大鼠海马齿状回神经前体细胞增殖明显,且可以向神经元和神经胶质细胞分化.     

次声激活小胶质细胞抑制成年大鼠海马神经干细胞增殖

目的:探讨次声对成年大鼠海马齿状回颗粒细胞下层(subgranular zone,SGZ)神经干细胞增殖抑制作用的细胞学机制。方法:成年雄性Sprague-Dawley大鼠置于次声压力舱,连续暴露于16 Hz、130 dB次声7 d(2h/d)后,给与小胶质细胞抑制剂米诺环素(50 mg/kg,药物组,n=16)或等体积生理盐水(对照组,n=16),同时设立不经次声作用的正常对照组(n=16);分别于1、3、7和14 d处死大鼠,利用免疫组织化学法以Iba1、OX42标记小胶质细胞,BrdU标记增殖的神经干细胞。结果:小胶质细胞在SGZ区分布较为密集;与正常对照组相比,次声暴露后3 d时OX42免疫反应性明显增强、SGZ区BrdU阳性细胞数目减少最为明显(P0.01);米诺环素可显著改善次声暴露后BrdU阳性细胞数目的减少(P0.01)。结论:小胶质细胞活化参与次声抑制成年大鼠海马SGZ区神经干细胞的增殖。     

局灶性脑缺血后侧脑室室下区神经发生及其与血管内皮生长因子关系的研究

为了研究成年大鼠局灶性脑缺血后侧脑室室下区(SVZ)神经发生的情况及其与血管内皮生长因子(VEGF)的关系,探讨脑缺血后神经发生及其调控机制,本研究通过大脑中动脉阻断法(MCAO)建立大鼠局灶性脑缺血模型,5-溴-2-脱氧尿核苷(BrdU)标记增殖的神经前体细胞,用免疫荧光双标记法动态检测BrdU、TuJ1、MAP-2、GFAP的表达,同时观察增殖细胞表达VEGF及其受体情况。结果显示:与对照组相比,大鼠SVZ的BrdU阳性细胞数在脑缺血后4 d组明显增加,14 d组达到高峰;Br-dU/TuJ1、BrdU/MAP-2阳性双标细胞数在脑缺血后14 d组开始增加,28 d组达到高峰;但BrdU/GFAP阳性双标细胞数则无明显变化;增殖的BrdU阳性细胞同时表达VEGF及其受体FLK-1。以上结果提示:大鼠局灶性脑缺血可激活SVZ自体神经前体细胞原位增殖、分化,且增殖的细胞同时表达VEGF及其受体可能是脑缺血后神经发生增强的调节机制之一。     

模拟失重后大鼠海马齿状回神经发生的实验研究

观察模拟失重对大鼠海马齿状回神经发生的影响,为进一步阐明模拟失重对成年大鼠海马齿状回神经发生影响的规律及其相关生物学机制提供基本的实验依据。采用尾部悬吊法建立大鼠模拟失重模型,通过5-溴-2’-脱氧尿苷(5-bromo-2’-de-oxyuridine,BrdU)标记分裂细胞、微管相关蛋白(doublecortin,DCX)标记神经干细胞、神经元核蛋白(NeuN)标记神经元及胶质原纤维酸性蛋白(GFAP)标记神经胶质细胞的单、双重免疫组织化学染色方法比较尾部悬吊后7、14、28d模拟失重组大鼠与相应时间对照组大鼠之间海马齿状回神经前体细胞增殖、迁移和分化的情况。结果显示:模拟失重后7、14d尾部悬吊法模拟失重大鼠齿状回的BrdU免疫阳性细胞数目较相应对照组明显减少(P<0.01),而模拟失重后28d时两组大鼠齿状回BrdU免疫阳性细胞数目无显著差异(P>0.05)。本研究结果提示,模拟失重可抑制海马齿状回神经发生的水平。     

成年肌萎缩脊髓侧索硬化症转基因鼠脊髓增殖细胞的分化

目的 探讨成年肌萎缩脊髓侧索硬化症(ALS)转基因模型鼠脊髓内增殖细胞的类型及分化情况. 方法 对ALS转基因鼠发病期进行BrdU标记,分别于不同时间点取材,冷冻切片,应用免疫荧光双标及三标染色技术检测ALS转基因鼠病变进展过程中脊髓内增殖细胞的分化情况. 结果 成年ALS转基因鼠发病期脊髓的中央管、灰质、白质均未检测到BrdU/DCX双标记阳性细胞和BrdU/NeuN双标记阳性细胞.灰质、白质和中央管周围检测到大量NG2阳性细胞,阳性细胞数量随病变进展逐渐减少,NG2阳性细胞多呈BrdU阳性表达;可检测到少量BrdU/A2B5双标记阳性细胞;ALS转基因鼠发病期脊髓BrdU/GFAP双标记阳性细胞较多,部分双阳性细胞呈Nestin阳性,而野生型鼠脊髓内未检测到BrdU/GFAP双标记阳性细胞.结论 神经退行性病变激活ALS转基因鼠脊髓内源性增殖细胞向神经胶质细胞方向分化,未检测到向神经元方向分化,内源性增殖细胞尚不能有效地促进退行性病变的修复.     

高原环境对小鼠成体神经发生的影响

目的:探索和研究我国青藏高原高海拔生存环境对于小鼠海马齿状回成体神经干细胞增殖和新生细胞分化的影响。方法:健康成年昆明小鼠分为两组,一组为1519 m海拔高度的兰州对照组,另一组为4547 m海拔高度的青藏高原沱沱河高原环境组。运用BrdU腹腔注射和免疫荧光组织化学相结合的方法研究和比较不同环境中齿状回内成体神经干细胞的增殖和新生细胞的分化。结果:高原环境组的BrdU免疫阳性细胞数与低海拔对照组相比减少了40%(P=0.001),而高原环境组小鼠齿状回中的BrdU/Prox-1标记的双阳性细胞在BrdU标记的阳性细胞中的百分比与对照组相比没有显著的差异(P=0.211),并且两组小鼠齿状回中90%以上的BrdU阳性细胞同时也被Prox-1标记。结论:在青藏高原的高海拔低氧环境中,小鼠海马内成体神经干细胞的增殖明显受抑制,然而新生的细胞向颗粒细胞的分化并没有受到明显的影响。     

γ-分泌酶抑制剂对脑缺血大鼠神经干细胞移植后神经保护作用

目的 探讨γ-分泌酶抑制剂（3,5-二氟苯乙酰基）-L-丙氨酰基-L-2-苯基甘氨酸叔丁酯（DAPT）对脑缺血大鼠神经干细胞（NSCs）移植后的神经保护作用。 方法 SD大鼠33只,脑缺血模型制造成功后,随机平均分为3组：模型组、神经干细胞移植组（移植组）、DAPT+移植组。另假手术组11只仅在麻醉状态下分离暴露血管。NSCs移植后7d观察各组大鼠神经行为学改变;TTC染色观察脑梗死体积;尼氏染色观察脑组织病理形态学变化;免疫荧光双标检测BrdU/神经元核抗原（NeuN）阳性细胞表达。 结果 假手术组神经功能学评分为零,无脑梗死灶,细胞形态完好,尼氏小体丰富,BrdU/NeuN阳性细胞表达阴性;与假手术组相比,模型组神经功能学评分增加,有明显神经功能缺损症状,可见明显脑梗死灶,神经细胞排列紊乱,可见核固缩,尼氏小体稀少,存活神经元数量显著减少(P＜0.05),有少量BrdU/NeuN阳性细胞表达(P＜0.05);与模型组比较,移植组和DAPT+移植组都有不同程度神经功能评分减低,脑梗死体积缩小,神经细胞存活数量增加( P＜0.05),BrdU/NeuN阳性细胞表达增多(P＜0.05),以DAPT+移植组各项指标恢复最为明显。 结论 DAPT能够促进移植的NSCs向神经元分化,对脑缺血大鼠神经干细胞移植后有神经保护作用。     

青春期大鼠癫痫发作后海马齿状回颗粒细胞层神经细胞增殖的改变

目的:探讨青春期大鼠癫痫发作后海马齿状回颗粒细胞层神经细胞数量的变化。方法:选择健康4周龄雄性SD大鼠,应用氯化锂-匹罗卡品药物点燃造模,造模成功后根据取脑组织时间分为24 h组、2周组、4周组,并设相应的对照组。溴脱氧尿嘧啶核苷(BrdU)标记后免疫荧光染色,用激光共聚焦观察大鼠海马齿状回(DG)颗粒细胞层BrdU阳性细胞。结果:24 h和2周实验组BrdU阳性细胞显著增多,分别较对照组增加55.1%和39.6%,2周实验组比24 h实验组降低15.5%(P<0.05);4周实验组BrdU阳性细胞数较对照组无明显差异(P>0.05)。结论:青春期大鼠癫痫发作可引起海马齿状回颗粒层神经细胞增殖的升高,但随着时间的延长有下降的趋势,至4周左右神经细胞的增殖趋于正常。     

脑缺血再灌注模型大鼠跑台运动后海马神经再生和血管内皮生长因子mRNA的变化

背景：研究表明跑台运动能促进健康大鼠海马的神经细胞再生。 目的：观察跑台运动对脑缺血再灌注模型大鼠海马神经再生和血管内皮生长因子mRNA表达的影响。 方法：用线栓法阻塞大脑中动脉以建立单侧脑缺血再灌注模型大鼠,将建模成功大鼠随机分为跑台运动组和安静对照组,另设假手术组。安静对照组和假手术组大鼠安静饲养,跑台运动组进行7 d跑台运动。跑台运动组和安静对照组大鼠在每天跑台运动前腹腔注射5-溴脱氧尿嘧啶核苷溶液。 结果与结论：免疫组织化学染色结果显示,跑台运动组大鼠双侧海马及齿状回5-溴脱氧尿嘧啶核苷阳性表达细胞数量显著多于安静对照组(P < 0.01)。实时荧光定量PCR检测结果显示,跑台运动组大鼠海马血管内皮生长因子mRNA表达水平显著高于安静对照组和假手术组(P < 0.05)。结果证实,跑台运动能够明显促进脑缺血再灌注大鼠海马神经细胞的再生并上调海马组织血管内皮生长因子的表达。     

Glia as a putative target for antidepressant treatments

BACKGROUND: Since the early 1950s, various molecular mechanisms have been invoked to explain how antidepressants work. The most recent suggests that pharmacologically stimulated adult neurogenesis might be involved. Surprisingly, in the adult brain, an important source of new neurons and possibly mediators of neurogenesis appears to be glia, i.e., astrocytes. We have recently shown that protracted administration of the antidepressant fluoxetine to adult rats upregulated the astrocytic protein S100beta content and increased neurogenesis in the hippocampus. METHODS: Rats were treated with fluoxetine for 21 days; before sacrifice bromodeoxyuridine (BrdU) was injected to label the proliferating cells. Immunofluorescence was used to identify proliferating BrdU-positive cells, and cells immunopositive for S100beta and its receptor receptor for advanced glycation end products (RAGE). RESULTS: Typically, S100beta-positive cells were observed in the vicinity of BrdU-positive cells. On the other hand, we observed colocalization of RAGE receptors and BrdU immunoreactivities, suggesting that some proliferating cells express these receptors for S100beta. RAGE expression by neuronal cells or neuronal precursors and its activation by S100beta may promote their survival. LIMITATIONS: The anatomical localization of hippocampal S100beta, its receptor RAGE, and BrdU-positive cells that we describe in this study is only indicative of a putative role for glia in antidepressant-stimulated neurogenesis. Functional in vitro and in vivo studies are needed to directly investigate this role; quantitative assays and time-course studies are also warranted. CONCLUSION: We propose that a better understanding of glia functioning could establish its role as a target for novel antidepressant treatments.     

Hippocampal neurogenesis is reduced by sleep fragmentation in the adult rat

The adult hippocampal dentate gyrus (DG) is a site of continuing neurogenesis. This process is influenced by a variety of physiological and experiential stimuli including total sleep deprivation (TSD). In humans, sleep fragmentation (SF) is a more common sleep condition than TSD. SF is associated with several prevalent diseases. We assessed a hypothesis that SF would suppress adult neurogenesis in the DG of the adult rat. An intermittent treadmill system was used; the treadmill was on for 3 s and off for 30 s (SF). For sleep fragmentation control (SFC), the treadmill was on for 15 min and off for 150 min. SF was conducted for three durations: 1, 4 and 7 days. To label proliferating cells, the thymidine analog, 5-bromo-2-deoxyuridine (BrdU), was injected 2 h prior to the end of each experiment. Expression of the intrinsic proliferative marker, Ki67, was also studied. SF rats exhibited an increased number of non-rapid eye movement (NREM) sleep bouts with no change in the percent of time spent in this stage. The numbers of both BrdU-positive cells and Ki67-positive cells were reduced by approximately 70% (P<0.05) in the SF groups after 4 and 7 days of experimental conditions whereas no differences were observed after 1 day. In a second experiment, we found that the percentage of new cells expressing a neuronal phenotype 3 weeks after BrdU administration was lower in the SF in comparison with the SFC group for all three durations of SF. We also examined the effects of SF on proliferation in adrenalectomized (ADX) animals, with basal corticosterone replacement. ADX SF animals exhibited a 55% reduction in the number of BrdU-positive cells when compared with ADX SFC. Thus, elevated glucocorticoids do not account for most of the reduction in cell proliferation induced by the SF procedure, although a small contribution of stress is not excluded. The results show that sustained SF induced marked reduction in hippocampal neurogenesis.     

Methadone does not alter key parameters of adult hippocampal neurogenesis in the heroin-naïve rat

Methadone is a synthetic opiate that is useful in a variety of clinical settings, including in maintenance therapy of heroin dependence and as an analgesic. However, methadone can have negative effects on cognition in humans and in rodents. The mechanisms underlying methadone-induced disruption in cognition are unknown. One possibility is that methadone disrupts adult hippocampal neurogenesis, a form of hippocampal plasticity involved in cognition that is disrupted by other opiates, like morphine. The goal of this study was to determine if methadone alters key parameters of hippocampal neurogenesis in the adult rat. Four groups of male rats were injected with saline (Saline, n=11) or methadone (Escalating, Short Term, Acute, n=10-11/group) over the course of three weeks. Weight gain, locomotor activity, and neurogenesis data were collected. Consistent with prior results, Escalating rats had slower weight gain (-4% vs. Saline). Also consistent with prior results, methadone did not alter locomotor activity over the course of a 90 min test. However, closer analysis revealed that methadone - irrespective of the dose or duration - led to a decrease in locomotor activity (-11 to -20% vs. saline) when examined during the first 5 min of the locomotor test. Surprisingly, methadone did not alter any of three quantified parameters relevant to adult hippocampal neurogenesis (number of Ki67-, doublecortin-, or BrdU-immunoreactive cells [BrdU given prior to saline/methadone exposure]). These results suggest that - unlike other opiates such as morphine - experimenter-delivered methadone does not alter hippocampal plasticity by decreasing the number of adult-generated neurons.     

不同年龄脑出血大鼠海马齿状回神经干细胞增殖与分化差异的比较

BACKGROUND:Cerebral hemorrhage can activate the proliferation and differentiation of neural stem cells in the dentate gyrus of the hippocampus. Through continuous differentiation and proliferation, endogenous neural stem cells can gradually replace aging and damaged neurons, thus protecting the brain structure. OBJECTIVE:To compare the difference of the proliferation and differentiation of neural stem cells in the dentate gyrus of the hippocampus of rats with different ages. METHODS:Ninety-six adult rats and 96 aged rats were randomly divided into normal group (n=18 per group), sham operation group (n=12 per group) and cerebral hemorrhage group (model group, n=66 per group), respectively. Cerebral hemorrhage models were made in the two model groups in which, the rats were subjected to cerebral hemorrhage for 6, 24, 48, 72 hours and 7 days, respectively. Then, brain tissues were collected to measure brain water content. BrdU/NeuN and BrdU/GFAP double staining were performed at 3, 7, 14, 21, 28 days after surgery to calculate the number of positive cells. RESULTS AND CONCLUSION:For both adult and aged rats, the brain water content was significantly higher than that in the normal group and sham operation group (P < 0.05), while in the normal and sham operation groups, the brain water content was significantly lower in the aged rats than the adult rats (P  < 0.05). The number of bilateral BrdU-positive cells in the adult and aged model groups was significantly higher than that in the corresponding normal and sham operation groups (P  < 0.05), and moreover, the positive cell number at the hemorrhage side was significantly higher than that at the opposite side (P < 0.05). In addition, the number of BrdU-positive cells at the hemorrhage side in the adult rats was significantly higher than that in the aged rats at different time after cerebral hemorrhage (P  < 0.05). Results from immunohistochemical double staining showed that the BrdU/NeuN and BrdU/GFAP expression in the hippocampal dentate gyrus of adult rats with cerebral hemorrhage was significantly higher than that of normal adult rats. All these experimental results show that there are a few neural stem cells proliferating in the hippocampal dentate gyrus of normal rats, and the proliferation ability is stronger in the adult rats than the aged rats. Cerebral hemorrhage can significantly strengthen the proliferation of neural stem cells in the dentate gyrus in the adult rats compared with the aged rats.     

Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats

In adult hippocampus, neural progenitor cells give rise to neurons throughout life, and the neurogenesis is modulated by various intrinsic and extrinsic factors. Recent reports showed that lesion of septal cholinergic nuclei projecting to hippocampus suppressed the survival of newborn cells in the dentate gyrus (DG) of hippocampus. Here, we studied whether pharmacological treatment to activate or inhibit the cholinergic system could modulate adult hippocampal neurogenesis. 5'-Bromo-2'-deoxyuridine (BrdU) was injected to label dividing cells before the drug treatment. Immunohistochemical analysis was performed in normal rats chronically treated with an acetylcholinesterase inhibitor donepezil or a muscarinic acetylcholine receptor blocker scopolamine for four weeks. Donepezil increased, but scopolamine decreased, the number of BrdU-positive cells in the DG as compared with the control. Neither drug altered the percentage of BrdU-positive cells that were also positive for a neuronal marker neuronal nuclei, nor net population of proliferative cells labeled with proliferating cell nuclear antigen. We also found that donepezil enhanced, and scopolamine suppressed, the expression level of phosphorylated cAMP response element binding protein (CREB), which is related to cell survival, in the DG. These results indicate that donepezil enhances and scopolamine suppresses the survival of newborn cells in the DG via CREB signaling without affecting neural progenitor cell proliferation and the neuronal differentiation. This is the first evidence that pharmacological manipulation of the cholinergic system can modulate adult hippocampal neurogenesis.     

NF-κB在发育鼠戊四氮反复点燃癫痫形成中的作用

目的：用NF-κB阻滞剂吡咯烷二硫基甲酸盐(PDTC)阻断NF-κB的表达，探讨核因子κB(NF-κB)在发育鼠戊四氮(PTZ)点燃癫痫形成过程中的作用。方法:生后10 d（P10）Wistar大鼠72只，随机分为PTZ组、PDTC＋PTZ组及生理盐水对照组3组，制备戊四氮反复点燃癫痫模型。观察各组大鼠行为学改变、海马各区细胞形态及细胞计数、NF-κB表达、5-溴-2-脱氧尿嘧啶核苷(BrdU)阳性细胞数和苔藓纤维发芽等指标。结果:(1)NF-κB表达，PTZ组显著高于对照组及PDTC+PTZ组（P<0.01）；(2)海马神经细胞计数，PTZ组齿状回（DG）区颗粒细胞较对照组显著增加(P<0.05)；PDTC+PTZ组CA1、CA3和门区神经元数较PTZ组均明显减少（P<0.05）；(3)DG区BrdU阳性细胞数，PTZ组和PDTC+PTZ组均较对照组显著增加（P<0.01）；PDTC＋PTZ组DG区BrdU阳性细胞数目明显较PTZ组少（P<0.01）；NF-κB吸光度值与BrdU阳性细胞数/颗粒细胞数相关性分析呈正相关，具有统计学意义（P<0.01）；（4）苔藓纤维发芽，PDTC＋PTZ组和PTZ组均有苔藓纤维发芽，两组比较没有显著差异。结论:NF-κB在发育鼠癫痫中发挥重要作用，促进海马神经元发生，保护海马神经细胞，但对苔藓纤维发芽无明显作用。     

慢性复合应激对成年大鼠海马NeuroD表达的影响

本实验通过观察慢性复合应激对成年大鼠海马NeuroD表达的影响,探讨慢性复合应激与海马神经发生的关系。将成年雄性大鼠32只随机分为慢性复合应激组(简称应激组)和正常对照组(简称对照组)。应激组动物每天不规律交替暴露于四种复合应激原中,共持续6周。然后运用免疫组织化学染色、Western-blot和RT-PCR技术分别观察海马内NeuroD阳性神经元数量、NeuroD蛋白水平和核酸水平的变化。结果显示:慢性复合应激组动物海马齿状回NeuroD阳性神经元数量明显增多(P<0.05);海马NeuroD蛋白的表达明显增强(P<0.05);海马NeuroD mRNA水平明显上调(P<0.05)。表明慢性复合应激可引起海马NeuroD阳性神经元数量增多和NeuroD表达水平升高,提示慢性复合应激可能促进大鼠海马的神经发生。     

MK-801诱发精神分裂症对大鼠探索能力、疼痛反应及海马神经细胞增殖的影响

目的:观察大鼠精神分裂症后探索能力、痛觉及海马齿状回颗粒细胞层神经细胞增殖的改变。方法:MK-801腹腔注射制备精神分裂症动物模型,分别监测给药后第1、5、10、14 d大鼠的探洞次数和甩尾时间。Brdu标记后取材,应用免疫荧光染色和激光共聚焦显微技术观察海马齿状回神经细胞的增殖情况。结果:①洞板试验:实验组大鼠的探洞次数较对照组显著下降(P<0.01),且随着MK-801给药时间的增加而减少(P<0.01);②甩尾试验:实验组大鼠对疼痛刺激的反应时间较对照组缩短(P<0.01),且随着MK-801给药时间的延长痛觉敏感度不断增加(P<0.01);③神经细胞的增殖:停药后第1 d,实验组海马齿状回颗粒层神经细胞增殖数较对照组减少(P<0.05),第16 d两组间无显著差异(P>0.05)。结纶:MK-801诱发精神分裂症后可致大鼠的探索能力减退、痛觉敏感,同时可降低海马齿状回颗粒细胞层神经细胞的增殖。